12
5
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6239 |
Palbociclib monohydrochloride
PD 0332991 hydrochloride,Palbociclib hydrochloride,帕布昔利布盐酸盐,Palbociclib (PD-0332991) HCl |
CDK | Cell Cycle/Checkpoint |
Palbociclib monohydrochloride (PD 0332991 hydrochloride) 是一种口服的细胞周期蛋白依赖性激酶 (CDK) 抑制剂,具有潜在的抗肿瘤活性。它抑制 CDK4和 CDK6,IC50分别为11 nM,16 nM。它有用于 ER 阳性和 HER2 阴性乳腺癌的研究潜力。 | |||
T6240 |
Palbociclib Isethionate
Palbociclib (PD0332991) Isethionate,帕博西尼羟乙基磺酸盐,PD 0332991 isethionate,帕布昔利布羟乙基磺酸盐 |
CDK | Cell Cycle/Checkpoint |
Palbociclib Isethionate (PD 0332991 isethionate) 是一种高选择性的CDK4/6抑制剂,IC50为11 nM 和16 nM。它对一组 36 种额外的蛋白激酶没有抑制作用。 | |||
T1785 |
Palbociclib
PD 0332991,帕博西尼,帕布昔利布 |
CDK | Cell Cycle/Checkpoint |
Palbociclib (PD 0332991) 是一种 CDK 抑制剂,抑制 CDK4 和 CDK6 (IC50=11/16 nM),具有口服活性。Palbociclib 具有抗肿瘤活性,有用于 ER 阳性和 HER2 阴性乳腺癌的研究潜力。 | |||
T63634 | Palbociclib dihydrochloride | ||
Palbociclib (PD 0332991) dihydrochloride 是口服具有活力的、选择性的 CDK4 (IC50: 11 nM) 和 CDK6 (IC50: 16 nM) 抑制剂。Palbociclib dihydrochloride 对癌细胞具有抗增殖活性,并阻滞细胞周期,能够用于 HR 阳性和 HER2 阴性乳腺癌,以及肝细胞癌的相关研究。 | |||
T28291 |
Palbociclib-Succinic acid
Palbociclib-hemi Succinic acid,Palbociclib-Succinate, |
||
Palbociclib-Succinic acid is a Palbociclib- derivative with a succinic acid linker. The carboxy group of Palbociclib-Succinic acid can be used to conjugate with other molecules such as peptides, proteins, or polymers. Palbociclib-Succinic acid is a useful | |||
T72507 |
Palbociclib orotate
PD 0332991 orotate |
CDK | Cell Cycle/Checkpoint |
Palbociclib (PD 0332991) orotate 是一种口服活性的CDK4和CDK6选择性抑制剂,其IC50值分别为11 nM和16 nM。该化合物对癌细胞展示出抗增殖效果,并促使细胞周期处于阻滞状态。该药物适用于HR阳性、HER2阴性乳腺癌以及肝细胞癌的研究。 | |||
T63576 | Palbociclib hydrochloride | ||
Palbociclib (PD 0332991) hydrochloride 是一种选择性的、有效的 CDK4 (IC50: 11 nM) 和 CDK6 (IC50: 16 nM)抑制剂。Palbociclib hydrochloride 对癌细胞具有抗增殖作用,并诱导细胞周期阻滞,能够用于 HR 阳性和 HER2 阴性乳腺癌,以及肝细胞癌的相关研究。 | |||
T78130 |
N-Methyl Palbociclib
|
Drug Metabolite | Metabolism |
N-MethylPalbociclib是一种Palbociclib的杂质。Palbociclib(PD 0332991)是一种口服活性的CDK4和CDK6抑制剂。 | |||
T12355 |
Palbociclib-d8
PD 0332991 D8,Palbociclib D8 |
CDK | Cell Cycle/Checkpoint |
Palbociclib D8 is a deuterium labeled Palbociclib. Palbociclib is a selective and orally active inhibitor of CDK4 and CDK6 (IC50s of 11 and 16 nM, respectively). | |||
T64486 | 6-Desacetyl Palbociclib | ||
6-Desacetyl Palbociclib 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T64486。 | |||
T33865 |
Palbociclib-SMCC
PD0332991-SMCC,Palbociclib-SMCC linker,PD 0332991-SMCC,PD-0332991-SMCC |
||
Palbociclib-SMCC is a Palbociclib derivative with a SMCC linker. | |||
T18515 |
Palbociclib-propargyl
PROTAC CDK6 ligand 1 |
Others | Others |
Palbociclib-propargyl, a PROTAC ligand targeting the protein CDK6, connects to the CRBN ligand through a PEG linker to form PROTAC CP-10. CP-10 exhibits a potent DC50 value of 2.1 nM against CDK6[1]. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1889 |
Lupalbigenin
|
ERK; Akt; Topoisomerase | Cytoskeletal Signaling; DNA Damage/DNA Repair; MAPK; PI3K/Akt/mTOR signaling |
Lupalbigenin sensitizes detachment-induced cell death in human lung cancer cell through down-regulation of pro-survival proteins. | |||
TN4308 |
Isolupalbigenin
|
Antifection | Microbiology/Virology |
Isolupalbigenin shows promising cytotoxic effects toward HL-60 cells (IC50 4.3 ± 0.7 to 18.0 ± 1.7 uM), it also shows in vitro inhibitory activity toward human glyoxalase I. Isolupalbigenin shows two different antibacterial activities against MRSA: direct growth inhibition and intensification of methicillin sensitivity, it could lead to the development of compounds for new approaches against MRSA infection. | |||
T82054 |
Ipalbine
|
||
Ipalbine为源自Ipomoea alba L的六氢吲哚生物碱类化合物。 | |||
T12353 |
Palbinone
|
Others | Others |
Palbinone is a terpenoid isolated from the roots of Paeonia albiflora Pallas, with anti-inflammatory activity. | |||
T82055 |
Ipalbidine
|
||
Ipalbidine为自ipomoea Hardwickii Hemsl中提炼的生物碱,显示出剂量依赖性镇痛效果。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01756 |
Transthyretin Protein, Human, Recombinant (His)
PALB,HEL111,CTS,transthyretin,CTS1,HsT2651,TBPA |
Human | HEK293 Cells |
Transthyretin Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 15.2 kDa and the accession number is E9KL36. | |||
TMPK-01090 |
Transthyretin/Prealbumin Protein, Cynomolgus, Recombinant (His)
Prealbumin,TBPA,CTS,HEL111,Transthyretin,TTR,ATTR,CTS1,HsT26... |
Cynomolgus | HEK293 Cells |
Transthyretin is a highly conserved homotetrameric protein, mainly synthetized by the liver and the choroid plexus of brain. The carrier role of TTR is well-known; however, many other functions have emerged, namely in the nervous system. TTR aggregates are responsible for many amyloidosis such as familial amyloidotic polyneuropathy and cardiomyopathy. Normal TTR can also aggregate and deposit in the heart of old people and in preeclampsia placental tissue. | |||
TMPY-00261 |
Meprin beta Protein, Human, Recombinant (His)
meprin A, β,Meprin β,meprin A, beta |
Human | HEK293 Cells |
MEP1B (Meprin A Subunit Beta) is a Protein Coding gene. This gene encodes the beta subunit. Targeted disruption of this gene in mice affects embryonic viability, renal gene expression profiles, and distribution of the membrane-associated alpha subunit in the kidney and intestine. Meprins are cell membrane, oligomeric metalloendopeptidases composed of two distinct but evolutionarily related subunits, alpha, and beta. MEP1A is mapped to the short arm of chromosome 6 by the use of radiation and som... |